×
ADVERTISEMENT

MARCH 26, 2024

CDC Offers Guidance for Abx Prophylaxis for Resistant Meningococcal Disease


Originally published by our sister publication Infectious Disease Special Edition

By Ethan Covey

In response to rising rates of meningococcal disease cases caused by ciprofloxacin-resistant strains of Neisseria meningitidis, the CDC issued implementation guidance for health departments regarding the use of antibiotic prophylaxis in resistant areas (MMWR Morb Mortal Wkly Rep 2024;73[5]:99-103).

“Meningococcal disease is a life-threatening illness requiring prompt antibiotic treatment for